Also, the SQSTM1-KLF4-associated prosurvival autophagy contributes to CFZ resistance in MM models [43], while blocking SQSTM1 suppresses myeloma growth and osteoclast formation in vitro and induces bone formation in myeloma-bearing bones in vivo [44]. The gene discussed is SQSTM1; the disease is Miyoshi myopathy.